Developing innovative therapies for the treatment of liver and metabolic diseases
Location: United States, Michigan, Kalamazoo
Employees: 11-50
Total raised: $40M
Founded date: 2015
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.04.2017 | Series A | $40M | - |
Mentions in press and media 6
| Date | Title | Description |
| 15.09.2018 | 40 AND UNDER: The Silicon Valley biotech stars who are backing startups aiming to cure disease, prolong life, and fix the food system | This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Putting millions of dollars into bold new technologies can be a delicate business when lives hang in the balance. But every day some of the... |
| 14.04.2017 | Cirius Therapeutics Inks $40M Series A | KALAMAZOO, MI, Cirius Therapeutics, previously known as Octeta Therapeutics, announced today the completion of a Series A financing of up to $40 million. >> Click here for more funding data on Cirius Therapeutics >> To expor... |
| 12.04.2017 | Term Sheet — Wednesday, April 12 | IP-NOPE Qualtrics, the Provo, Utah-based enterprise software company famous for bootstrapping in its early years, has raised $180 million in new venture funding, valuing it at $2.5 billion. It’s a surprising move for the 15-year-old company... |
| 11.04.2017 | Cirius Therapeutics Closes up to $40m Series A Financing | Cirius Therapeutics (fka Octeta Therapeutics), a Kalamazoo, Mich.- and San Diego, CA-based clinical-stage pharmaceutical company focused on developing therapies to treat liver disease, closed a Series A financing of up to $40m. The round wa... |
| 11.04.2017 | Two new Series A rounds inject $72M into regenerative medicine and NASH | Headquartered in Woburn, Massachusetts, Frequency Therapeutics was founded in 2015 with a mission to kickstart one of the body’s natural healing mechanisms. Its $32 million Series A financing round was led by CoBro Ventures, with support fr... |
| - | Two new Series A rounds inject $72M into regenerative medicine and NASH | Two of the hottest fields in biopharma got another injection of cash this week, with a combined $72 million in Series A financing. That includes $32 million raised by Frequency Therapeutics to further its novel regenerative medicine approac... |